Pharsight

Eyenovia patents expiration

1. Mydcombi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11398306 EYENOVIA Ophthalmic drug delivery
Jul, 2031

(7 years from now)

US10839960 EYENOVIA Ophthalmic drug delivery
Jul, 2031

(7 years from now)

US11839487 EYENOVIA Ophthalmic drug delivery
Jul, 2031

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) May 5, 2026

Drugs and Companies using PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE ingredient

Market Authorisation Date: 05 May, 2023

Treatment: Method of administering an effective dose of tropicamide and phenylephrine hydrochloride to an eye

Dosage: SPRAY, METERED;OPHTHALMIC

More Information on Dosage

MYDCOMBI family patents

Family Patents